SecBot SecBot
3 ·Filed Nov 12, 2026
WW

WWB

WINDWARD BIO GROUP AG
NEUTRAL
Impact 2/10
Horizonimmediate Processed4d 3h ago SEC0001361712-26-000007
Actionable Insight • Neutral

These are standard initial beneficial ownership filings by two insiders. No trading activity or change in position is reported. Monitor for future Form 4 filings that would indicate actual transactions.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$28.50
T+0 close · Nov 12, 2026 · via day close
Latest settled
+5.40%
T+1 · $30.04
Vs SPY
+7.32%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $28.50entry
  2. T+1 · 15h ago +5.40%α +7.32% · $30.04
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two Form 3 filings were filed on November 12, 2026 by Otello Stampacchia and Sandip Kapadia, each reporting initial beneficial ownership of Windward Bio Group AG securities. Stampacchia disclosed indirect ownership of 1,262,628 common shares via Omega Fund VII, L.P., 1,262,626 common shares via Omega Fund VIII, L.P., 531,632 common shares via Omega Fund VII, L.P. (Series B), and 531,634 common shares via Omega Fund VIII, L.P. (Series B). Kapadia filed a Form 3 with no securities reported. These are routine initial ownership disclosures with no material financial impact.

Key Facts

  • Otello Stampacchia filed Form 3 on November 12, 2026, reporting indirect beneficial ownership of common shares through Omega Fund VII, L.P. and Omega Fund VIII, L.P.
  • Stampacchia indirectly holds 1,262,628 common shares (Series A) via Omega Fund VII, 1,262,626 common shares (Series A) via Omega Fund VIII, 531,632 common shares (Series B) via Omega Fund VII, and 531,634 common shares (Series B) via Omega Fund VIII.
  • Sandip Kapadia filed Form 3 on November 12, 2026, reporting no securities beneficially owned.
  • Both filings include a power of attorney authorizing Scott Applebaum, Diego Ramos, and Claudia D'Augusta to execute future Forms 3, 4, and 5.
  • The issuer is Windward Bio Group AG, a biological products company based in Basel, Switzerland.

Financial Impact

No financial impact; initial ownership disclosures only.

Risk Factors

  • No material risks identified from these filings.

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (WWB), Batch item 10001361712-26-000007
Document: 0001361712-26-000007-index-headers.html0001677141-26-000009
Document: 0001361712-26-000007-index.html0001361712-26-000007
Document: 0001361712-26-000007.txt0001361712-26-000007
3 Filing (WWB), Batch item 50001677141-26-000009
Document: 0001677141-26-000009-index-headers.html0001361712-26-000007
Document: 0001677141-26-000009-index.html0001361712-26-000007
Document: 0001677141-26-000009.txt0001361712-26-000007

US Market Status

Market Closed · Opens Wed (11h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026